Report cover image

NA Liquid Biopsy Market - Industry Trends and Forecast to 2030

Publisher Data Bridge Market Research
Published May 01, 2023
Length 260 Pages
SKU # DAABD18011524

Description

NA Liquid Biopsy Market - Industry Trends and Forecast to 2030


North America liquid biopsy market is expected to reach USD 3,832.25 million by 2030 from USD 1,260.50 million in 2022, growing at a CAGR of 15.9% during the forecast period of 2023 to 2030.
Market Segmentation:
Liquid Biopsy Market, By Product (Instruments, Consumables & Accessories, Services & Software), Biomarker Type (Circulating Tumor Cells (CTCS), Circulating Cell-Free DNA (CFDNA), Cell-free RNA, Extracellular Vesicles, Exosomes, and Others), Sample Type (Blood Sample Based, Urine Sample Based, Saliva & Other Tissue Fluid Sample-Based, and Others), Analytical Type (Molecular, Proteomics, and Histology/Imaging), Application Type (Cancer Applications and Non-Cancer Applications), Clinical Application (Routine Screening, Patient Work-Up, Therapy Selection, Treatment Monitoring, Recurrence Monitoring, and Others), Technology (Multi-Gene Parallel Analysis, and Single-Gene Analysis), End User (Hospitals, Reference Laboratories, Diagnostic Centers, Research Centers & Academic Institutes, and Others), Distribution Channel (Direct Tender, Third Party Distributor, and Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2030


Overview of North America Liquid Biopsy Market Dynamics:

Driver

• Technological advancements in liquid biopsy platforms

Restrain
• Lack of standardized guidelines
Opportunity

• Increasing reimbursements and government support for liquid biopsy
Market Players:

Some of the key market players operating in the North America liquid biopsy market are listed below:

• F. Hoffmann-La Roche Ltd
• Guardant Health
• Thermo Fisher Scientific Inc.
• Exact Sciences Corporation(Genomic health)
• QIAGEN
• Labcorp
• Johnson & Johnson Services, Inc.
• Illumina Inc
• mdxhealth.
• NeoGenomics Laboratories
• Bio-Rad Laboratories, Inc.
• Natera, Inc.
• CARDIFF ONCOLOGY, INC.
• PathAI
• STRECK
• BIOCEPT, INC.
• Sysmex Inostics Inc.,
• Fluxion Biosciences Inc
• Epic Sciences
• Predicine
• ANGLE plc
• Oncocyte Corporation



Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.

Table of Contents

260 Pages
1 Introduction 60
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The North America Liquid Biopsy Market
1.4 Limitations
1.5 Markets Covered
2 Market Segmentation 66
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Multivariate Modelling
2.7 Product Type Lifeline Curve
2.8 Primary Interviews With Key Opinion Leaders
2.9 Dbmr Market Position Grid
2.10 Market Testing Type Coverage Grid
2.11 Vendor Share Analysis
2.12 Secondary Sources
2.13 Assumptions
3 Executive Summary 78
4 Premium Insights 81
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 Industry Insights: 84
6 North America Liquid Biopsy Market, Regulation 85
7 Market Overview 87
7.1 Drivers
7.1.1 Growing Demand For Non-invasive Liquid Biopsy Technique
7.1.2 Advancements In Precision Medicine Due To Liquid Biopsy
7.1.3 Increasing Cancer Prevalence And Awareness
7.1.4 Technological Advancements In Liquid Biopsy Platforms
7.2 Restraints
7.2.1 High Cost Of Liquid Biopsy Tests
7.2.2 Lack Of Standardized Guidelines
7.3 Opportunities
7.3.1 Integration Of Artificial Intelligence (Ai) And Machine Learning
7.3.2 Increasing Reimbursements And Government Support For Liquid Biopsy
7.3.3 Increasing R&D Activities By Institutes
7.4 Challenges
7.4.1 Lack Of Skilled Professionals Performing Liquid Biopsy
7.4.2 Increased Dependency On Other Biopsies
8 North America Liquid Biopsy Market, By Product 99
8.1 Overview
8.2 Consumables & Accessories
8.2.1 Test Kits
8.2.1.1 Total Nucleic Acid Isolation Kit
8.2.1.2 Dna Isolation Kit
8.2.1.3 Others
8.2.2 Collection Tubes
8.2.2.1 50 Pieces
8.2.2.2 100 Pieces
8.2.3 Assays
8.2.3.1 Flexible Reagents
8.2.3.2 Scalable Reagents
8.2.3.3 Others
8.2.4 Control Kit
8.2.5 Others
8.3 Instruments
8.3.1 Analyzers
8.3.2 Systems
8.3.3 Others
8.4 Services & Software
8.4.1 Ngs Analysis And Reporting Software
8.4.2 Dpcr Analysis Software
8.4.3 Castpcr Analysis Software
8.4.4 Others
9 North America Liquid Biopsy Market, By Biomaker Type 109
9.1 Overview
9.2 Circulating Tumor Cells (Ctcs)
9.3 Circulating Cell-free Dna (Cfdna)
9.4 Cell-free Rna
9.5 Exosomes
9.6 Extracellular Vesicles
9.7 Others
10 North America Liquid Biopsy Market, By Sample Type 119
10.1 Overview
10.2 Blood Sample-based
10.3 Urine Sample-based
10.4 Saliva & Other Tissue Fluids Sample-based
10.5 Others
11 North America Liquid Biopsy Market, By Analytical Type 127
11.1 Overview
11.2 Molecular
11.2.1 Ngs
11.2.2 Pcr
11.2.3 Microarray
11.2.4 Proteomics
11.2.5 Others
11.3 Proteomic
11.3.1 Ngs
11.3.2 Pcr
11.3.3 Microarray
11.3.4 Proteomics
11.3.5 Others
11.4 Histology/Imaging
12 North America Liquid Biopsy Market, By Application Type 135
12.1 Overview
12.2 Cancer Applications
12.2.1 Lung
12.2.2 Breast
12.2.2.1 Early Breast Cancer
12.2.2.2 Advanced Breast Cancer
12.2.3 Colorectal
12.2.4 Prostrate
12.2.5 Liver
12.2.6 Others
12.3 Non-cancer Applications
12.3.1 Prenatal Diagnosis
12.3.2 Personalized Immunotherapy
12.3.3 Others
13 North America Liquid Biopsy Market, By Clinical Application 143
13.1 Overview
13.2 Routine Screening
13.3 Therapy Selection
13.4 Treatment Monitoring
13.4.1 Early-stage Disease
13.4.2 Late-stage/Metastatic Disease
13.5 Recurrence Monitoring
13.6 Patient Work-up
13.7 Others
14 North America Liquid Biopsy Market, By Technology 152
14.1 Overview
14.2 Multi-gene-parallel Analysis
14.3 Single Gene Analysis
15 North America Liquid Biopsy Market, By End User 158
15.1 Overview
15.2 Hospitals
15.3 Reference Laboratories
15.4 Diagnostic Centers
15.5 Research Centers And Academic Institutes
15.6 Others
16 North America Liquid Biopsy Market, By Distribution Channel 166
16.1 Overview
16.2 Direct Tender
16.3 Third Party Distributor
16.4 Others
17 North America Liquid Biopsy Market, By Region 172
17.1 North America
17.1.1 U.S.
17.1.2 Canada
17.1.3 Mexico
18 North America Liquid Biopsy Market, Company Landscape 214
18.1 Company Share Analysis: North America
19 Company Profile 215
19.1 F. Hoffmann-la Roche Ltd.
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Developments
19.2 Guardant Health
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Developments
19.3 Thermo Fisher Scientific Inc.
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Company Share Analysis
19.3.4 Swot Analysis
19.3.5 Product Portfolio
19.3.6 Recent Developments
19.4 Exact Science Corporation
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Company Share Analysis
19.4.4 Product Portfolio
19.4.5 Recent Developments
19.5 Qiagen
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Company Share Analysis
19.5.4 Product Portfolio
19.5.5 Recent Developments
19.6 Angle Plc (2022)
19.6.1 Company Snapshot
19.6.2 Revenue Analysis
19.6.3 Product Portfolio
19.6.4 Recent Development
19.7 Biocept, Inc.
19.7.1 Company Snapshot
19.7.2 Revenue Analysis
19.7.3 Product Portfolio
19.7.4 Recent Development
19.8 Bio-rad Laboratories, Inc. (2022)
19.8.1 Company Snapshot
19.8.2 Revenue Analysis
19.8.3 Product Portfolio
19.8.4 Recent Developments
19.9 Epic Sciences
19.9.1 Company Snapshot
19.9.2 Product Portfolio
19.9.3 Recent Developments
19.10 Fluxion Biosciences Inc
19.10.1 Company Snapshot
19.10.2 Product Portfolio
19.10.3 Recent Developments
19.11 Illumina, Inc.
19.11.1 Company Snapshot
19.11.2 Revenue Analysis
19.11.3 Swot Analysis
19.11.4 Product Portfolio
19.11.5 Recent Development
19.12 Johnson & Johnson Private Limited
19.12.1 Company Snapshot
19.12.2 Revenue Analysis
19.12.3 Swot Analysis
19.12.4 Product Portfolio
19.12.5 Recent Developments
19.13 Laboratory Corporation Of America Holdings
19.13.1 Company Snapshot
19.13.2 Revenue Analysis
19.13.3 Swot Analysis
19.13.4 Product Portfolio
19.13.5 Recent Development
19.14 Mdxhealth
19.14.1 Company Snapshot
19.14.2 Revenue Analysis
19.14.3 Product Portfolio
19.14.4 Recent Developments
19.15 Menarini Silicon Biosystems
19.15.1 Company Snapshot
19.15.2 Product Portfolio
19.15.3 Recent Developments
19.16 Natera, Inc.
19.16.1 Company Snapshot
19.16.2 Revenue Analysis
19.16.3 Product Portfolio
19.16.4 Recent Developments
19.17 Neogenomics Laboratories
19.17.1 Company Snapshot
19.17.2 Revenue Analysis
19.17.3 Product Portfolio
19.17.4 Recent Developments
19.18 Oncocyte Corporation
19.18.1 Company Profile
19.18.2 Service Portfolio
19.18.3 Recent Developments
19.19 Pathai
19.19.1 Company Snapshot
19.19.2 Product Portfolio
19.19.3 Recent Developments
List Of Tables
Table 1 Ways In Which Liquid Biopsy Has Advanced Precision Medicine
Table 2 North America Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 3 North America Consumables & Accessories In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 4 North America Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 5 North America Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 6 North America Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 7 North America Assays In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 8 North America Instruments In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 9 North America Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 10 North America Services & Software In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 11 North America Services & Software In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 12 North America Liquid Biopsy Market, By Biomaker Type, 2021-2030 (Usd Million)
Table 13 North America Circulating Tumor Cells (Ctcs) In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 14 North America Circulating Cell-free Dna (Cfdna) In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 15 North America Cell-free Rna In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 16 North America Exosomes In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 17 North America Extracellular Vesicles In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 18 North America Others In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 19 North America Liquid Biopsy Market, By Sample Type, 2021-2030 (Usd Million)
Table 20 North America Blood Sample-based In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 21 North America Urine Sample-based In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 22 North America Saliva & Other Tissue Fluids Sample-based In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 23 North America Others In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 24 North America Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 25 North America Molecular In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 26 North America Molecular In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 27 North America Proteomic In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 28 North America Proteomic In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 29 North America Histology/Imaging In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 30 North America Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 31 North America Cancer Applications In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 32 North America Cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 33 North America Breast In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 34 North America Non-cancer Applications In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 35 North America Non-cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 36 North America Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 37 North America Routine Screening In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 38 North America Therapy Selection In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 39 North America Treatment Monitoring In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 40 North America Treatment Monitoring In Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 41 North America Recurrence Monitoring In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 42 North America Patient Work-up In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 43 North America Others In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 44 North America Liquid Biopsy Market, By Technology, 2021-2030 (Usd Million)
Table 45 North America Multi-gene-parallel Analysis In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 46 North America Single Gene Analysis In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 47 North America Liquid Biopsy Market, By End User, 2021-2030 (Usd Million)
Table 48 North America Hospitals In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 49 North America Reference Laboratories In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 50 North America Diagnostics Centers In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 51 North America Research Centres And Academic Institutes In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 52 North America Others In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 53 North America Liquid Biopsy Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 54 North America Direct Tender In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 55 North America Third Party Distributor In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 56 North America Others In Liquid Biopsy Market, By Region, 2021-2030 (Usd Million)
Table 57 North America Liquid Biopsy Market, By Country, 2021-2030 (Usd Million)
Table 58 North America Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 59 North America Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 60 North America Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 61 North America Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 62 North America Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 63 North America Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 64 North America Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 65 North America Assays In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 66 North America Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 67 North America Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 68 North America Services & Software In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 69 North America Liquid Biopsy Market, By Biomaker Type, 2021-2030 (Usd Million)
Table 70 North America Liquid Biopsy Market, By Sample Type, 2021-2030 (Usd Million)
Table 71 North America Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 72 North America Molecular In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 73 North America Proteomic In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 74 North America Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 75 North America Cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 76 North America Breast In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 77 North America Non-cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 78 North America Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 79 North America Treatment Monitoring In Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 80 North America Liquid Biopsy Market, By Technology, 2021-2030 (Usd Million)
Table 81 North America Liquid Biopsy Market, By End User, 2021-2030 (Usd Million)
Table 82 North America Liquid Biopsy Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 83 U.S. Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 84 U.S. Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 85 U.S. Consumable & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 86 U.S. Liquid Biopsy Market, By Product, 2021-2030 (Asp)
Table 87 U.S. Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 88 U.S. Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 89 U.S. Test Kits In Liquid Biopsy Market, By Products, 2021-2030 (Asp)
Table 90 U.S. Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 91 U.S. Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 92 U.S. Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Asp)
Table 93 U.S. Assays In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 94 U.S. Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 95 U.S. Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 96 U.S. Instruments In Liquid Biopsy Market, By Products, 2021-2030 (Asp)
Table 97 U.S. Services & Software In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 98 U.S. Liquid Biopsy Market, By Biomaker Type, 2021-2030 (Usd Million)
Table 99 U.S. Liquid Biopsy Market, By Sample Type, 2021-2030 (Usd Million)
Table 100 U.S. Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 101 U.S. Molecular In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 102 U.S. Proteomic In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 103 U.S. Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 104 U.S. Cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 105 U.S. Breast In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 106 U.S. Non-cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 107 U.S. Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 108 U.S. Treatment Monitoring In Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 109 U.S. Liquid Biopsy Market, By Technology, 2021-2030 (Usd Million)
Table 110 U.S. Liquid Biopsy Market, By End User, 2021-2030 (Usd Million)
Table 111 U.S. Liquid Biopsy Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 112 Canada Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 113 Canada Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 114 Canada Consumable & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 115 Canada Liquid Biopsy Market, By Product, 2021-2030 (Asp)
Table 116 Canada Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 117 Canada Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 118 Canada Test Kits In Liquid Biopsy Market, By Products, 2021-2030 (Asp)
Table 119 Canada Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 120 Canada Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 121 Canada Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Asp)
Table 122 Canada Assays In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 123 Canada Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 124 Canada Instruments In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 125 Canada Instruments In Liquid Biopsy Market, By Products, 2021-2030 (Asp)
Table 126 Canada Services & Software In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 127 Canada Liquid Biopsy Market, By Biomaker Type, 2021-2030 (Usd Million)
Table 128 Canada Liquid Biopsy Market, By Sample Type, 2021-2030 (Usd Million)
Table 129 Canada Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 130 Canada Molecular In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 131 Canada Proteomic In Liquid Biopsy Market, By Analytical Type, 2021-2030 (Usd Million)
Table 132 Canada Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 133 Canada Cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 134 Canada Breast In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 135 Canada Non-cancer Applications In Liquid Biopsy Market, By Application Type, 2021-2030 (Usd Million)
Table 136 Canada Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 137 Canada Treatment Monitoring In Liquid Biopsy Market, By Clinical Application, 2021-2030 (Usd Million)
Table 138 Canada Liquid Biopsy Market, By Technology, 2021-2030 (Usd Million)
Table 139 Canada Liquid Biopsy Market, By End User, 2021-2030 (Usd Million)
Table 140 Canada Liquid Biopsy Market, By Distribution Channel, 2021-2030 (Usd Million)
Table 141 Mexico Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 142 Mexico Consumables & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 143 Mexico Consumable & Accessories In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 144 Mexico Liquid Biopsy Market, By Product, 2021-2030 (Asp)
Table 145 Mexico Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 146 Mexico Test Kits In Liquid Biopsy Market, By Product, 2021-2030 (Units)
Table 147 Mexico Test Kits In Liquid Biopsy Market, By Products, 2021-2030 (Asp)
Table 148 Mexico Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Usd Million)
Table 149 Mexico Collection Tubes In Liquid Biopsy Market, By Product, 2021-2030 (Units)
List Of Figures
Figure 1 North America Liquid Biopsy Market: Segmentation
Figure 2 North America Liquid Biopsy Market: Data Triangulation
Figure 3 North America Liquid Biopsy Market: Droc Analysis
Figure 4 North America Liquid Biopsy Market: North America Vs Regional Market Analysis
Figure 5 North America Liquid Biopsy Market: Company Research Analysis
Figure 6 North America Liquid Biopsy Market: Interview Demographics
Figure 7 North America Liquid Biopsy Market: Dbmr Market Position Grid
Figure 8 North America Liquid Biopsy Market: Market Testing Type Coverage Grid
Figure 9 North America Liquid Biopsy Market: Vendor Share Analysis
Figure 10 North America Liquid Biopsy Market: Segmentation
Figure 11 The Growing Demand For Non-invasive Cancer Diagnostics Is Expected To Drive The North America Liquid Biopsy Market Growth In The Forecast Period
Figure 12 Consumables & Accessories Segment Is Expected To Account For The Largest Share Of The North America Liquid Biopsy Market In 2023 & 2030
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of The North America Liquid Biopsy Market
Figure 14 Advantages Of Liquid Biopsy Over Traditional Biopsy
Figure 15 North America Liquid Biopsy Market: By Product, 2022
Figure 16 North America Liquid Biopsy Market: By Product, 2023-2030 (Usd Million)
Figure 17 North America Liquid Biopsy Market: By Product, Cagr (2023-2030)
Figure 18 North America Liquid Biopsy Market: By Product, Lifeline Curve
Figure 19 North America Liquid Biopsy Market: By Biomaker Type, 2022
Figure 20 North America Liquid Biopsy Market: By Biomaker Type, 2023-2030 (Usd Million)
Figure 21 North America Liquid Biopsy Market: By Biomaker Type, Cagr (2023-2030)
Figure 22 North America Liquid Biopsy Market: By Biomaker Type, Lifeline Curve
Figure 23 North America Liquid Biopsy Market: By Sample Type, 2022
Figure 24 North America Liquid Biopsy Market: By Sample Type, 2023-2030 (Usd Million)
Figure 25 North America Liquid Biopsy Market: By Sample Type, Cagr (2023-2030)
Figure 26 North America Liquid Biopsy Market: By Sample Type, Lifeline Curve
Figure 27 North America Liquid Biopsy Market: By Analytical Type, 2022
Figure 28 North America Liquid Biopsy Market: By Analytical Type, 2023-2030 (Usd Million)
Figure 29 North America Liquid Biopsy Market: By Analytical Type, Cagr (2023-2030)
Figure 30 North America Liquid Biopsy Market: By Analytical Type, Lifeline Curve
Figure 31 North America Liquid Biopsy Market: By Application Type, 2022
Figure 32 North America Liquid Biopsy Market: By Application Type, 2023-2030 (Usd Million)
Figure 33 North America Liquid Biopsy Market: By Application Type, Cagr (2023-2030)
Figure 34 North America Liquid Biopsy Market: By Application Type, Lifeline Curve
Figure 35 North America Liquid Biopsy Market: By Clinical Application, 2022
Figure 36 North America Liquid Biopsy Market: By Clinical Application, 2023-2030 (Usd Million)
Figure 37 North America Liquid Biopsy Market: By Clinical Application, Cagr (2023-2030)
Figure 38 North America Liquid Biopsy Market: By Clinical Application, Lifeline Curve
Figure 39 North America Liquid Biopsy Market: By Technology, 2022
Figure 40 North America Liquid Biopsy Market: By Technology, 2023-2030 (Usd Million)
Figure 41 North America Liquid Biopsy Market: By Technology, Cagr (2023-2030)
Figure 42 North America Liquid Biopsy Market: By Technology, Lifeline Curve
Figure 43 North America Liquid Biopsy Market: By End User, 2022
Figure 44 North America Liquid Biopsy Market: By End User, 2023-2030 (Usd Million)
Figure 45 North America Liquid Biopsy Market: By End User, Cagr (2023-2030)
Figure 46 North America Liquid Biopsy Market: By End User, Lifeline Curve
Figure 47 North America Liquid Biopsy Market: By Distribution Channel, 2022
Figure 48 North America Liquid Biopsy Market: By Distribution Channel, 2023-2030 (Usd Million)
Figure 49 North America Liquid Biopsy Market: By Distribution Channel, Cagr (2023-2030)
Figure 50 North America Liquid Biopsy Market: By Distribution Channel, Lifeline Curve
Figure 51 North America Liquid Biopsy Market: Snapshot (2022)
Figure 52 North America Liquid Biopsy Market: By Country (2022)
Figure 53 North America Liquid Biopsy Market: By Country (2023 & 2030)
Figure 54 North America Liquid Biopsy Market: By Country (2022 & 2030)
Figure 55 North America Liquid Biopsy Market: By Product (2023-2030)
Figure 56 North America Liquid Biopsy Market: Company Share 2022 (%) 174

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us